The pattern of thyroiditis in multiple sclerosis: a cross-sectional study in a tertiary care hospital in Egypt

The Egyptian Journal of Internal Medicine

Table 3 Logistic regression analysis to determine the variable associated with DMDs in MS patients with thyroiditis

Model		Unstandardized coefficients		Standardized coefficients	t	Sig.	95.0% confidence interval for B
Model		B	Std. error	Beta	t	Sig.	Lower bound	Upper bound
1	(Constant)	0.456	0.085		5.368	˂ 0.001*	0.287	0.625
	FT3	− 0.056	0.033	0.066	− 1.707	0.091	− 0.121	0.009
	FT4	0.180	0.032	0.211	5.613	˂ 0.001*	0.116	0.243
	TSH	− 0.068	0.010	− 0.295	− 6.687	˂ 0.001*	− 0.088	− 0.048
	Anti-TPO	− 0.004	0.001	− 0.658	− 5.302	˂ 0.001*	− 0.005	− 0.002
	Anti-TG	− 0.037	0.014	− 0.093	− 2.540	˂ 0.05*	− 0.065	− 0.008
	WBC count	− 0.003	0.001	− 0.147	− 4.944	˂ 0.001*	− 0.004	− 0.002
	Hemoglobin	− 0.017	0.010	− 0.075	− 1.741	0.085	− 0.037	0.002
	Platelet	− 0.005	0.001	− 0.367	− 7.098	˂ 0.001*	− 0.006	− 0.003
	Neutrophil count	0.023	0.006	0.143	3.663	˂ 0.001*	0.011	0.036
	hs-CRP	0.021	0.007	0.135	2.926	˂ 0.05*	0.007	0.036

TSH thyroid-stimulating hormone, FT3 free triidothyronine, FT4 free thyroxine, anti-TG anti-thyroglobulin antibodies, anti-TPO anti-thyroid peroxidase antibodies, TRAb thyroid receptor antibody, WBC white blood cell, CRP C-reactive protein, DMDs disease-modifying drugs
*P < 0.05